Reference number : 236-2017-2018-Q2-00232, amendment number : , agreement type : G, recipient legal name : Cybulsky, Myron I, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5G 2C4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 3246739.0, agreement start date : 2017-07-01, agreement end date : 2024-06-30, description english : Cellular and molecular mechanisms regulating the progression of atherosclerosis: exploiting macrophage reverse transendothelial migration as a therapeutic strategy, description french : Cellular and molecular mechanisms regulating the progression of atherosclerosis: exploiting macrophage reverse transendothelial migration as a therapeutic strategy, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2017-18 to 2024-25), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2017-18 à 2024-25), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada